1. Home
  2. IPHA
  3. IPHA News

Latest Innate Pharma S.A. ADS (IPHA) News on December 22, 2024

Innate Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
IPHA

Business Wire

2 days ago

Innate Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

3 Promising Penny Stocks With Market Caps Under US$300M
IPHA

Simply Wall St.

10 days ago

3 Promising Penny Stocks With Market Caps Under US$300M

Innate Pharma SA Reveals Promising Lacutamab Trial Results
IPHA

TipRanks

12 days ago

Innate Pharma SA Reveals Promising Lacutamab Trial Results

Innate Pharma Presents Lacutamab Improved Health-related Quality of Life Data at ASH 2024 From TELLOMAK Phase 2 Study in Patients With Cutaneous T Cell Lymphoma
IPHA

Business Wire

13 days ago

Innate Pharma Presents Lacutamab Improved Health-related Quality of Life Data at ASH 2024 From TELLOMAK Phase 2 Study in Patients With Cutaneous T Cell Lymphoma

IPHA

MT Newswires

16 days ago

Sector Update: Health Care Stocks Edge Higher Premarket Friday

IPHA

MT Newswires

16 days ago

Innate Pharma, Institute for Follicular Lymphoma Collaborate to Study IPH6501 in Follicular Lymphoma

Innate Pharma and the Institute for Follicular Lymphoma Innovation (IFLI) Announce up to $7.9M Investment From IFLI to Support IPH6501 Development in Follicular Lymphoma
IPHA

Business Wire

16 days ago

Innate Pharma and the Institute for Follicular Lymphoma Innovation (IFLI) Announce up to $7.9M Investment From IFLI to Support IPH6501 Development in Follicular Lymphoma

Innate Pharma Highlights Abstracts Selected for the ASH Annual Meeting 2024
IPHA

Business Wire

19 days ago

Innate Pharma Highlights Abstracts Selected for the ASH Annual Meeting 2024

Innate Pharma Releases Its 2025 Financial Calendar
IPHA

Business Wire

a month ago

Innate Pharma Releases Its 2025 Financial Calendar

Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET® IPH6501
IPHA

Business Wire

a month ago

Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET® IPH6501

Discover 3 Promising Penny Stocks With Over US$90M Market Cap
IPHA

Simply Wall St.

a month ago

Discover 3 Promising Penny Stocks With Over US$90M Market Cap

Innate Pharma Reports Third Quarter 2024 Business Update and Financial Results
IPHA

Business Wire

a month ago

Innate Pharma Reports Third Quarter 2024 Business Update and Financial Results

Innate Pharma Highlights Data From Its Innovative Oncology Portfolio Selected for the SITC Annual Meeting 2024
IPHA

Business Wire

a month ago

Innate Pharma Highlights Data From Its Innovative Oncology Portfolio Selected for the SITC Annual Meeting 2024

Innate Pharma Announces Conference Call and Webcast for Third Quarter 2024 Results and Business Updates
IPHA

Business Wire

a month ago

Innate Pharma Announces Conference Call and Webcast for Third Quarter 2024 Results and Business Updates

Innate Pharma Announces Its Participation in Upcoming Investor Conferences
IPHA

Business Wire

2 months ago

Innate Pharma Announces Its Participation in Upcoming Investor Conferences

IPHA

MT Newswires

2 months ago

Innate Pharma Names Jonathan Dickinson as New CEO, Chairman

Innate Pharma Appoints Jonathan Dickinson as New Chief Executive Officer and Chairman of the Executive Board
IPHA

Business Wire

2 months ago

Innate Pharma Appoints Jonathan Dickinson as New Chief Executive Officer and Chairman of the Executive Board

Innate Pharma to Host KOL Scientific Symposium on Immunotherapy in New York on October 3, 2024
IPHA

Business Wire

3 months ago

Innate Pharma to Host KOL Scientific Symposium on Immunotherapy in New York on October 3, 2024

IPHA

MT Newswires

3 months ago

Innate Pharma Receives FDA Clearance for Phase 1 Trial of Cancer Treatment; Shares Rise

FDA grants IND clearance for Innate Pharma’s solid tumour trial
IPHA

Clinical Trials Arena

3 months ago

FDA grants IND clearance for Innate Pharma’s solid tumour trial

Innate Pharma Announces FDA Clearance of the IND for IPH4502, a Nectin-4 ADC to Be Developed in Solid Tumors
IPHA

Business Wire

3 months ago

Innate Pharma Announces FDA Clearance of the IND for IPH4502, a Nectin-4 ADC to Be Developed in Solid Tumors

Innate Pharma Reports First Half 2024 Business Update and Financial Results
IPHA

Business Wire

3 months ago

Innate Pharma Reports First Half 2024 Business Update and Financial Results

Innate Pharma SA: Monalizumab Data From NeoCOAST-2 Phase 2 Study in Early-Stage NSCLC Presented at the WCLC 2024
IPHA

Business Wire

3 months ago

Innate Pharma SA: Monalizumab Data From NeoCOAST-2 Phase 2 Study in Early-Stage NSCLC Presented at the WCLC 2024

Innate Pharma Announces Conference Call and Webcast for First Half 2024 Financial Results and Business Update
IPHA

Business Wire

4 months ago

Innate Pharma Announces Conference Call and Webcast for First Half 2024 Financial Results and Business Update

Innate Pharma Announces Its Participation in the H.C. Wainwright 26th Annual Global Investment Conference
IPHA

Business Wire

4 months ago

Innate Pharma Announces Its Participation in the H.C. Wainwright 26th Annual Global Investment Conference

Innate Pharma Announces Its Participation in Upcoming Investor Conference
IPHA

Business Wire

5 months ago

Innate Pharma Announces Its Participation in Upcoming Investor Conference

Number of Shares and Voting Rights of Innate Pharma as of July 10, 2024
IPHA

Business Wire

5 months ago

Number of Shares and Voting Rights of Innate Pharma as of July 10, 2024

Number of Shares and Voting Rights of Innate Pharma as of June 10, 2024
IPHA

Business Wire

6 months ago

Number of Shares and Voting Rights of Innate Pharma as of June 10, 2024

IPHA

MT Newswires

6 months ago

Innate Pharma Reports 'Promising and Durable' Results From Phase 1/2 Monotherapy Targeting Blood Cancers

Innate Pharma Shares Updated Results From the Sanofi Developed Blood Cancer Phase 1/2 SAR443579/IPH6101 Trial
IPHA

Business Wire

6 months ago

Innate Pharma Shares Updated Results From the Sanofi Developed Blood Cancer Phase 1/2 SAR443579/IPH6101 Trial

Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Mycosis Fungoides
IPHA

Business Wire

7 months ago

Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Mycosis Fungoides

Innate Pharma Announces Its Participation in Upcoming Investor Conferences
IPHA

Business Wire

7 months ago

Innate Pharma Announces Its Participation in Upcoming Investor Conferences

Innate Pharma Highlights Abstracts Selected for ASCO 2024 Annual Meeting
IPHA

Business Wire

7 months ago

Innate Pharma Highlights Abstracts Selected for ASCO 2024 Annual Meeting

Outcome of Innate Pharma’s 2024 Annual General Meeting
IPHA

Business Wire

7 months ago

Outcome of Innate Pharma’s 2024 Annual General Meeting

Innate Pharma: Clarification Regarding SAR443579 Designation
IPHA

Business Wire

7 months ago

Innate Pharma: Clarification Regarding SAR443579 Designation

Innate Pharma Highlights Abstracts Selected for EHA 2024 Congress
IPHA

Business Wire

7 months ago

Innate Pharma Highlights Abstracts Selected for EHA 2024 Congress

Innate Pharma Reports First Quarter 2024 Business Update and Financial Results
IPHA

Business Wire

7 months ago

Innate Pharma Reports First Quarter 2024 Business Update and Financial Results

Innate Pharma Announces Conference Call and Webcast for Q1 2024 Business Update
IPHA

Business Wire

8 months ago

Innate Pharma Announces Conference Call and Webcast for Q1 2024 Business Update

Innate Pharma Announces Advancement of Sanofi-developed NK Cell Engager SAR443579 / IPH6101 Progressing to Phase 2 for Blood Cancer Patients
IPHA

Business Wire

8 months ago

Innate Pharma Announces Advancement of Sanofi-developed NK Cell Engager SAR443579 / IPH6101 Progressing to Phase 2 for Blood Cancer Patients

Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 23, 2024
IPHA

Business Wire

8 months ago

Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 23, 2024

All You Need to Know About Innate Pharma (IPHA) Rating Upgrade to Buy
IPHA

Zacks

8 months ago

All You Need to Know About Innate Pharma (IPHA) Rating Upgrade to Buy

Innate Pharma Presents at AACR 2024 Preclinical Efficacy of Its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate
IPHA

Business Wire

8 months ago

Innate Pharma Presents at AACR 2024 Preclinical Efficacy of Its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate

Innate Pharma Announces Its Participation in Upcoming Investor Conference
IPHA

Business Wire

8 months ago

Innate Pharma Announces Its Participation in Upcoming Investor Conference

Innate Pharma Files Its 2023 Universal Registration Document (Document d’enregistrement Universel) and 2023 Annual Report on Form 20-F
IPHA

Business Wire

9 months ago

Innate Pharma Files Its 2023 Universal Registration Document (Document d’enregistrement Universel) and 2023 Annual Report on Form 20-F

Innate Pharma S.A. (NASDAQ:IPHA) Q4 2023 Earnings Call Transcript
IPHA

Insider Monkey

9 months ago

Innate Pharma S.A. (NASDAQ:IPHA) Q4 2023 Earnings Call Transcript

Innate Pharma Reports Full Year 2023 Financial Results and Business Update
IPHA

Business Wire

9 months ago

Innate Pharma Reports Full Year 2023 Financial Results and Business Update

Innate Pharma Announces Its Participation to Upcoming Investor Conference
IPHA

Business Wire

9 months ago

Innate Pharma Announces Its Participation to Upcoming Investor Conference

Innate Pharma Announces Conference Call and Webcast for Full Year 2023 Financial Results
IPHA

Business Wire

9 months ago

Innate Pharma Announces Conference Call and Webcast for Full Year 2023 Financial Results

Innate Pharma: First Patient dosed in Phase 1/2 study of IPH6501 in relapsed /refractory B-Cell non-Hodgkin’s Lymphoma
IPHA

Business Wire

10 months ago

Innate Pharma: First Patient dosed in Phase 1/2 study of IPH6501 in relapsed /refractory B-Cell non-Hodgkin’s Lymphoma

Innate Pharma to Present Nectin-4 Antibody Drug Conjugate IPH45 Preclinical Data at AACR 2024
IPHA

Business Wire

10 months ago

Innate Pharma to Present Nectin-4 Antibody Drug Conjugate IPH45 Preclinical Data at AACR 2024

Innate Pharma Announces Its Participation to Upcoming Investor Conference
IPHA

Business Wire

10 months ago

Innate Pharma Announces Its Participation to Upcoming Investor Conference

EZCORP, Inc. (NASDAQ:EZPW) Q1 2024 Earnings Call Transcript
IPHA

Insider Monkey

a year ago

EZCORP, Inc. (NASDAQ:EZPW) Q1 2024 Earnings Call Transcript

Unveiling Accuray (ARAY) Q2 Outlook: Wall Street Estimates for Key Metrics
IPHA

Zacks

a year ago

Unveiling Accuray (ARAY) Q2 Outlook: Wall Street Estimates for Key Metrics

IPHA

Associated Press Finance

a year ago

Red River Bancshares: Q4 Earnings Snapshot

Immutep Quarterly Activities Report Q2 FY24
IPHA

GlobeNewswire

a year ago

Immutep Quarterly Activities Report Q2 FY24

Medical Product Stocks' Q4 Earnings Due on Jan 30: SYK & More
IPHA

Zacks

a year ago

Medical Product Stocks' Q4 Earnings Due on Jan 30: SYK & More

Southern Missouri Bancorp Inc Reports Modest Earnings Growth in Q2 Fiscal 2024
IPHA

GuruFocus.com

a year ago

Southern Missouri Bancorp Inc Reports Modest Earnings Growth in Q2 Fiscal 2024

Accuray's (ARAY) CyberKnife S7 to Enhance Radiation Treatment
IPHA

Zacks

a year ago

Accuray's (ARAY) CyberKnife S7 to Enhance Radiation Treatment

IPHA

Business Wire

a year ago

ClearBridge MLP Funds Announce Proposed Mergers and Updates for Tender Offers

Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray CyberKnife® System, a Robotic Delivery Device That Makes Extremely Precise Radiation Treatments Possible in 1-5 Sessions
IPHA

PR Newswire

a year ago

Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray CyberKnife® System, a Robotic Delivery Device That Makes Extremely Precise Radiation Treatments Possible in 1-5 Sessions

NaaS Technology's Full Portfolio of Charging Pile Products Obtained CE Certification from the European Union
IPHA

PR Newswire

a year ago

NaaS Technology's Full Portfolio of Charging Pile Products Obtained CE Certification from the European Union

RumbleON, Inc. (NASDAQ:RMBL) insiders have recently purchased stock and their bets paid off last week as company hit US$261m market cap
IPHA

Simply Wall St.

a year ago

RumbleON, Inc. (NASDAQ:RMBL) insiders have recently purchased stock and their bets paid off last week as company hit US$261m market cap

The Zacks Analyst Blog Highlights GIII Apparel, Acushnet, Hooker Furniture, Netflix and Royal Caribbean Cruises
IPHA

Zacks

a year ago

The Zacks Analyst Blog Highlights GIII Apparel, Acushnet, Hooker Furniture, Netflix and Royal Caribbean Cruises

Alerus (ALRS) Misses Q4 Earnings Estimates
IPHA

Zacks

a year ago

Alerus (ALRS) Misses Q4 Earnings Estimates

First Bank Announces Fourth Quarter 2023 Net Income of $8.4 Million and Full Year Net Income of $20.9 Million
IPHA

GlobeNewswire

a year ago

First Bank Announces Fourth Quarter 2023 Net Income of $8.4 Million and Full Year Net Income of $20.9 Million

Bristow Enters Into New Long-term Equipment Financing for up to £55 Million
IPHA

PR Newswire

a year ago

Bristow Enters Into New Long-term Equipment Financing for up to £55 Million

Blue Foundry Bancorp Reports Fourth Quarter and Year-End 2023 Results
IPHA

GlobeNewswire

a year ago

Blue Foundry Bancorp Reports Fourth Quarter and Year-End 2023 Results

Bar Harbor Bankshares (BHB) Q4 Earnings and Revenues Beat Estimates
IPHA

Zacks

a year ago

Bar Harbor Bankshares (BHB) Q4 Earnings and Revenues Beat Estimates

ORIC Pharmaceuticals Announces $125 Million Private Placement Financing
IPHA

GlobeNewswire

a year ago

ORIC Pharmaceuticals Announces $125 Million Private Placement Financing

IPHA

Business Wire

a year ago

Franklin Templeton Fund Adviser, LLC Announces Distributions for the Month of February 2024

Why Earnings Season Could Be Great for Southern First (SFST)
IPHA

Zacks

a year ago

Why Earnings Season Could Be Great for Southern First (SFST)

Southern First (SFST) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
IPHA

Zacks

a year ago

Southern First (SFST) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Data Analytics Stocks Q3 Highlights: Palantir (NYSE:PLTR)
IPHA

StockStory

a year ago

Data Analytics Stocks Q3 Highlights: Palantir (NYSE:PLTR)

Blade Air Mobility to Present at 26th Annual Needham Growth Conference
IPHA

GlobeNewswire

a year ago

Blade Air Mobility to Present at 26th Annual Needham Growth Conference

TeraWulf Announces Appointment of New Independent Directors to the Board
IPHA

GlobeNewswire

a year ago

TeraWulf Announces Appointment of New Independent Directors to the Board

Number of Shares and Voting Rights of Innate Pharma as of January 1, 2024
IPHA

Business Wire

a year ago

Number of Shares and Voting Rights of Innate Pharma as of January 1, 2024

Charles Brandes Adjusts Position in Netgear Inc
IPHA

GuruFocus.com

a year ago

Charles Brandes Adjusts Position in Netgear Inc

Institutional investors may adopt severe steps after Magnachip Semiconductor Corporation's (NYSE:MX) latest 10% drop adds to a year losses
IPHA

Simply Wall St.

a year ago

Institutional investors may adopt severe steps after Magnachip Semiconductor Corporation's (NYSE:MX) latest 10% drop adds to a year losses

Data Analytics Stocks Q3 Recap: Benchmarking Domo (NASDAQ:DOMO)
IPHA

StockStory

a year ago

Data Analytics Stocks Q3 Recap: Benchmarking Domo (NASDAQ:DOMO)

Blue Foundry Bancorp Schedules Fourth Quarter & Year-End 2023 Earnings Conference Call
IPHA

GlobeNewswire

a year ago

Blue Foundry Bancorp Schedules Fourth Quarter & Year-End 2023 Earnings Conference Call

NaaS Technology Debuts at CES 2024 with Cutting-Edge EV Innovations, Pioneering Green Energy Solutions
IPHA

PR Newswire

a year ago

NaaS Technology Debuts at CES 2024 with Cutting-Edge EV Innovations, Pioneering Green Energy Solutions

Apellis Pharmaceuticals, Inc. (APLS) Soars 14.7%: Is Further Upside Left in the Stock?
IPHA

Zacks

a year ago

Apellis Pharmaceuticals, Inc. (APLS) Soars 14.7%: Is Further Upside Left in the Stock?

Q3 Earnings Highs And Lows: Amplitude (NASDAQ:AMPL) Vs The Rest Of The Data Analytics Stocks
IPHA

StockStory

a year ago

Q3 Earnings Highs And Lows: Amplitude (NASDAQ:AMPL) Vs The Rest Of The Data Analytics Stocks

Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Financial Highlights
IPHA

GlobeNewswire

a year ago

Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Financial Highlights

Entravision Announces Massive Expansion of Spanish-Language News Coverage
IPHA

Business Wire

a year ago

Entravision Announces Massive Expansion of Spanish-Language News Coverage

IPHA

Business Wire

a year ago

ClearBridge MLP and Midstream Total Return Fund Inc. Announces Unaudited Balance Sheet Information as of December 31, 2023

Shareholders in Cerus (NASDAQ:CERS) are in the red if they invested three years ago
IPHA

Simply Wall St.

a year ago

Shareholders in Cerus (NASDAQ:CERS) are in the red if they invested three years ago

An Intrinsic Calculation For Entravision Communications Corporation (NYSE:EVC) Suggests It's 43% Undervalued
IPHA

Simply Wall St.

a year ago

An Intrinsic Calculation For Entravision Communications Corporation (NYSE:EVC) Suggests It's 43% Undervalued

Nurix Therapeutics Outlines 2024 Strategic Priorities with Advancement of Targeted Protein Modulation Pipeline in Cancer and Autoimmune Diseases
IPHA

GlobeNewswire

a year ago

Nurix Therapeutics Outlines 2024 Strategic Priorities with Advancement of Targeted Protein Modulation Pipeline in Cancer and Autoimmune Diseases

Volaris Reports December 2023 Traffic Results: 85% Load Factor
IPHA

GlobeNewswire

a year ago

Volaris Reports December 2023 Traffic Results: 85% Load Factor

Innate Pharma (IPHA) Gains as FDA Lifts Hold on Lymphoma Study
IPHA

Zacks

a year ago

Innate Pharma (IPHA) Gains as FDA Lifts Hold on Lymphoma Study

Innate Pharma Announces U.S. FDA Lifts Partial Clinical Hold on Lacutamab Clinical Program
IPHA

Business Wire

a year ago

Innate Pharma Announces U.S. FDA Lifts Partial Clinical Hold on Lacutamab Clinical Program

Innate Pharma Strengthens Leadership and Appoints Two New Members to Its Executive Board
IPHA

Business Wire

a year ago

Innate Pharma Strengthens Leadership and Appoints Two New Members to Its Executive Board

Magnachip to Participate in the 26th Annual Needham Growth Conference
IPHA

PR Newswire

a year ago

Magnachip to Participate in the 26th Annual Needham Growth Conference

Nurix Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
IPHA

GlobeNewswire

a year ago

Nurix Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference

Cipher Mining Announces December 2023 Operational Update
IPHA

GlobeNewswire

a year ago

Cipher Mining Announces December 2023 Operational Update

11 Best Psychedelic Stocks to Buy in 2024
IPHA

Insider Monkey

a year ago

11 Best Psychedelic Stocks to Buy in 2024

Sight Sciences Announces Withdrawal of Final LCDs on Micro-Invasive Glaucoma Surgery from Five Medicare Administrative Contractors
IPHA

GlobeNewswire

a year ago

Sight Sciences Announces Withdrawal of Final LCDs on Micro-Invasive Glaucoma Surgery from Five Medicare Administrative Contractors

IPHA

Business Wire

a year ago

Templeton Dragon Fund, Inc. ("TDF") Announces Final Results of Tender Offer

IPHA

Business Wire

a year ago

ClearBridge MLP and Midstream Fund Inc., ClearBridge Energy Midstream Opportunity Fund Inc. and ClearBridge MLP and Midstream Fund Total Return Inc. Announce Plans for Tender Offers

Share on Social Networks: